C. Beadman

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.

R. Kurek, T. Ruhstaller, D. Cunningham, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Longterm effects of preoperative carbohydrate loading for colorectal surgery

C. Beadman, 2011 .

Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer

M. Socinski, R. Kurek, Michael Thomas, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study.

R. Kurek, T. Ruhstaller, M. Valladares-Ayerbes, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.